论文部分内容阅读
目的研究探索一种联合用药方法,对急性脑梗死患者进行静脉给药的临床疗效观察。方法将急性脑梗死患者,随机分为两组进行用药观察,联合用药组(46例)和常规单一用药组(37例)进行临床治疗及结论分析。两组年龄,性别,发病及用药时间均无差异。结果联合用药组及常规用药组,两组治疗的临床疗效均达95%,联合组的显著效果明显高于常规组的显著效果。两组结果相比,有显著差异(p<0.05),两组均未发生大量脑出血及严重其它部位出血。结论静脉内联用uk及PGE1对急性脑梗死患者能降低病死率、致残率,可减少并发症的发生率,此治疗方法是一种疗效高、副作用小且安全可靠的治疗方法。
Objective To explore a combination of drug treatment methods for patients with acute cerebral infarction intravenous clinical efficacy. Methods Patients with acute cerebral infarction were randomly divided into two groups for observation and treatment, combined treatment group (46 cases) and conventional single treatment group (37 cases) for clinical treatment and conclusion analysis. There was no difference between the two groups in terms of age, sex, incidence and medication time. Results The combined treatment group and conventional treatment group, the clinical efficacy of both groups were up to 95%, the significant effect of the combined group was significantly higher than the conventional group of significant effect. There was a significant difference between the two groups (p <0.05), with no significant intracerebral haemorrhage and severe bleeding elsewhere in either group. Conclusion Intravenous uk and PGE1 can reduce mortality and morbidity in patients with acute cerebral infarction, and can reduce the incidence of complications. This treatment is a safe and reliable treatment method with high efficacy, small side effects.